Search results for: 'CHINA pharmaceutical market'

The Greater China NAMA solution market was dominated by China, followed by Hong Kong and Taiwan and on-premises NAMA solution remained the preferred deployment option in the region. Evolving profit-driven targeted attacks and rapidly transforming advanced threats in the region drive the need to look into stronger detection and protection capabiliti...

This research service provides in-depth analyses on 6 therapeutic markets in Uganda, Kenya, and Tanzania. It also quantifies and forecasts the total pharmaceutical industry and the contribution from the script- and over-the-counter markets. It further indicates the contribution from the public- and private sectors to the total industry value. The r...

This research service provides a detailed overview and analysis of ten specialty pharmaceutical companies. They have been chosen by taking into account certain critical indicators such as revenues, research and development (R&D) expenditure, current drug pipeline, earnings per share, stock price appreciation, return on investment, and net income.

This study discusses the VoIP services market in China. It provides in-depth analysis of country-specific issues, such as market drivers and restraints, industry challenges and trends. It also provides a market size estimate, a forecast of traffic minutes and revenues and a market share breakdown. The China VoIP Services study is part of the Chi...

The packaging industry plays a major role in the pharmaceutical market. It not only provides containment and drug safety, but also ensures identity, convenience of handling, and delivery. It needs to balance complex considerations. Pharmaceutical packaging firms are some of the industry’s most innovative companies, as has been evident in the last 1...

The research service aims to analyse and assess the global generics pharmaceutical market, map the key trends and dynamics shaping the industry sector and provide strategic recommendations for the success of the market participants. With several key blockbuster drugs losing patent protection and new healthcare reforms being introduced by the Govern...

The car sharing market in China has approximately 30 active operators. These companies are operated by automotive original equipment manufacturers (OEMs), transportation companies and start-ups. The top 5 operators—EVCard (by SAIC Motor Co., Ltd.), Weigongjiao (by Geely), GoFun (by Beijing Shouqi Group Co., Ltd.), MoreFun (by BAIC Mobility Co., Ltd...

The discovery of new drug targets for diseases with unmet medical needs has long been hindered by the complexity of processing and interpreting massive volumes of biological data. The increasing volume and veracity of clinical and research data compels the use of enabling tools and technologies, such as cloud computing, AI, machine learning, natura...